Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VULCANize: Neoadjuvant Paclitaxel and Carboplatin in Vulvar Cancer
NCT04192253Phase 2Recruiting
- Sponsor
- Netherlands Cancer Institute
- Start
- Jan 2020
- Primary completion
- Jan 2024
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of paclitaxel, carboplatin in vulvar cancer, sponsored by Netherlands Cancer Institute. Started Jan 2020; status: recruiting.
02
Drugs
paclitaxelcarboplatin
03
Conditions
vulvar cancer
Beyond the preview
Go deeper on NCT04192253.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04192253.